دورية أكاديمية

Prevalence and Management of Anaemia in Renal Transplant Recipients: Data from Ten European Centres.

التفاصيل البيبلوغرافية
العنوان: Prevalence and Management of Anaemia in Renal Transplant Recipients: Data from Ten European Centres.
المؤلفون: Molnar, Miklos Zsolt, Mucsi, Istvan, Macdougall, Iain C., Marsh, James E., Yaqoob, Magdi, Main, John, Courtney, Aisling E., Fogarty, Damien, Mikhail, Ashraf, Choukroun, Gabriel, Short, Colin D., Covic, Adrian, Goldsmith, David J.
المصدر: Nephron Clinical Practice; Jan2011, Vol. 117 Issue 2, pc127-c134, 8p, 2 Charts, 3 Graphs
مصطلحات موضوعية: KIDNEY transplantation, RENAL anemia, ERYTHROPOIESIS, HEMOGLOBINS, CROSS-sectional method, ANALYSIS of variance
مصطلحات جغرافية: EUROPE
مستخلص: Background: Although it is a known predictor of mortality, there is a relative lack of recent information about anaemia in kidney transplant recipients. Thus, we now report data about the prevalence and management of post-transplant anaemia (PTA) in Europe 5 years after the TRansplant European Survey on Anemia Management (TRESAM) study. Methods: In a cross-sectional study enrolling the largest number of patients to date, data were obtained from 5,834 patients followed at 10 outpatient transplant clinics in four European countries using the American Society of Transplantation anaemia guideline. Results: More than one third (42%) of the patients were anaemic. The haemoglobin (Hb) concentration was significantly correlated with the estimated glomerular filtration rate (eGFR) (r = 0.4, p < 0.001). In multivariate analysis, eGFR, serum ferritin, age, gender, time since transplantation and centres were independently and significantly associated with Hb. Only 24% of the patients who had a Hb concentration <110 g/l were treated with an erythropoiesis-stimulating agent. The prevalence of anaemia and also the use of erythropoiesis-stimulating agents were significantly different across the different centres, suggesting substantial practice variations. Conclusions: PTA is still common and under-treated. The prevalence and management of PTA have not changed substantially since the TRESAM survey. Copyright © 2010 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
Copyright of Nephron Clinical Practice is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:16602110
DOI:10.1159/000319660